Download PDF
Synthesis 2011(17): 2733-2736  
DOI: 10.1055/s-0030-1260103
SPECIALTOPIC
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of 1,2,3-Triazole Elements in Histamine H3 Receptor Ligands

Miriam Walter, Tim Kottke, Lilia Weizel, J. Stephan Schwed, Holger Stark*
Johann Wolfgang Goethe University, Institute of Pharmaceutical Chemistry, Biocenter, ZAFES/OSF/NeFF/CMP/ICNF, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany
Fax: +49(69)79829352; e-Mail: h.stark@pharmchem.uni-frankfurt.de;
Further Information

Publication History

Received 25 February 2011
Publication Date:
08 July 2011 (online)

    Permissions and Reprints All articles of this category

Abstract

1,2,3-Triazole moieties were introduced in a histamine H3 receptor antagonist pharmacophore blueprint with a versatile click chemistry approach, yielding potent ligands. Azide and alkynes were combined under copper(I) catalysis to provide the triazole element. Conventional synthesis, as well as microwave irradiation, was successfully applied.

Key words

azides - alkynes - copper catalysis - click chemistry - histamine H3 receptor

    References

  • 1a Leurs R. Bakker RA. Timmerman H. de Esch IJ. Nat. Rev. Drug Discovery  2005,  4:  1070 
    Google Scholar
  • 1b Tiligada E. Zampeli E. Sander K. Stark H. Expert Opin. Invest. Drugs  2009,  18:  1519 
    Google Scholar
  • 2a Raddatz R. Tao M. Hudkins RL. Curr. Top. Med. Chem.  2010,  10:  153 
    Google Scholar
  • 2b Brioni JD. Esbenshade TA. Garrison TR. Bitner SR. Cowart MD. J. Pharmacol. Exp. Ther.  2011,  336:  38 
    Google Scholar
  • 2c Walter M. Stark H. Front. Biosci.  2011,  in press
    Google Scholar
  • 3a Celanire S. Wijtmans M. Talaga P. Leurs R. de Esch IJ. Drug Discovery Today  2005,  10:  1613 
    Google Scholar
  • 3b Celanire S. Lebon F. Stark H. In The Third Histamine Receptor: Selective Ligands as Potential Therapeutic Agents in CNS Disorders   Vohora DS. Taylor & Francis, CRC Press Inc.; Boca Raton: 2008.  p.103 
    Google Scholar
  • 3c Sander K. von Coburg Y. Camelin JC. Ligneau X. Rau O. Schubert-Zsilavecz M. Schwartz JC. Stark H. Bioorg. Med. Chem. Lett.  2010,  20:  1581 
    Google Scholar
  • 4a Denonne F. Atienzar F. Celanire S. Christophe B. Delannois F. Delaunoy C. Delporte ML. Durieu V. Gillard M. Lallemand B. Lamberty Y. Lorent G. Vanbellinghen A. Van Houtvin N. Verbois V. Provins L. ChemMedChem  2010,  5:  206 
    Google Scholar
  • 4b Davenport AJ. Stimson CC. Corsi M. Vaidya D. Glenn E. Jones TD. Bailey S. Gemkow MJ. Fritz U. Hallett DJ. Bioorg. Med. Chem. Lett.  2010,  20:  5165 
    Google Scholar
  • 4c Rao AU. Palani A. Chen X. Huang Y. Aslanian RG. West RE. Williams SM. Wu RL. Hwa J. Sondey C. Lachowicz J. Bioorg. Med. Chem. Lett.  2009,  19:  6176 
    Google Scholar
  • 4d Swanson DM. Shah CR. Lord B. Morton K. Dvorak LK. Mazur C. Apodaca R. Xiao W. Boggs JD. Feinstein M. Wilson SJ. Barbier AJ. Bonaventure P. Lovenberg TW. Carruthers NI. Eur. J. Med. Chem.  2009,  44:  4413 
    Google Scholar
  • 4e Celanire S. Wijtmans M. Christophe B. Collart P. de Esch I. Dassesse D. Delaunoy C. Denonne F. Durieu V. Gelens E. Gillard M. Lallemand B. Lamberty Y. Lebon F. Nicolas JM. Quere L. Snip E. Vanbellinghen A. Van Houtvin N. Verbois V. Timmerman H. Talaga P. Leurs R. Provins L. ChemMedChem  2009,  4:  1063 
    Google Scholar
  • 4f Walter M. von Coburg Y. Isensee K. Sander K. Ligneau X. Camelin JC. Schwartz JC. Stark H. Bioorg. Med. Chem. Lett.  2010,  20:  5879 
    Google Scholar
  • 4g Walter M. Isensee K. Kottke T. Ligneau X. Camelin JC. Schwartz JC. Stark H. Bioorg. Med. Chem. Lett.  2010,  20:  5883 
    Google Scholar
  • 5 Huisgen R. In 1,3-Dipolar Cycloaddition Chemistry   Vol. 1:  Padwa A. Wiley; New York: 1984.  p.1 
    Google Scholar
  • 6 Rostovtsev VV. Green LG. Fokin VV. Sharpless KB. Angew. Chem. Int. Ed.  2002,  41:  2596 
    Google Scholar
  • 7 Kolb HC. Sharpless KB. Drug Discovery Today  2003,  8:  1128 
    CrossrefPubMedGoogle Scholar
  • 8 Sander K. Kottke T. Hoffend C. Walter M. Weizel L. Camelin JC. Ligneau X. Schneider EH. Seifert R. Schwartz JC. Stark H. Org. Lett.  2010,  12:  2578 
    CrossrefGoogle Scholar
  • 9a Ligneau X. Morisset S. Tardivel-Lacombe J. Gbahou F. Ganellin CR. Stark H. Schunack W. Schwartz JC. Arrang JM. Br. J. Pharmacol.  2000,  131:  1247 
    Google Scholar
  • 9b Ligneau X. Perrin D. Landais L. Camelin JC. Calmels TP. Berrebi-Bertrand I. Lecomte JM. Parmentier R. Anaclet C. Lin JS. Bertaina-Anglade V. la Rochelle CD. d’Aniello F. Rouleau A. Gbahou F. Arrang JM. Ganellin CR. Stark H. Schunack W. Schwartz JC. J. Pharmacol. Exp. Ther.  2007,  320:  365 
    Google Scholar
  • 10 Kottke T. Sander K. Weizel L. Schneider EH. Seifert R. Stark H. Eur. J. Pharmacol.  2011,  654:  200 
    CrossrefGoogle Scholar
  • 11 Rodionov VO. Fokin VV. Finn MG. Angew. Chem. Int. Ed.  2005,  44:  2210 
    CrossrefPubMedGoogle Scholar
  • 12a Amon M. Ligneau X. Schwartz JC. Stark H. Bioorg. Med. Chem. Lett.  2006,  16:  1938 
    Google Scholar
  • 12b Ju Y. Kumar D. Varma RS. J. Org. Chem.  2006,  71:  6697 
    Google Scholar
  • 12c Isensee K. Amon M. Galaparti A. Ligneau X. Camelin JC. Capet M. Schwartz JC. Stark H. Bioorg. Med. Chem. Lett.  2009,  19:  2172 
    Google Scholar
  • 13 Appukkuttan P. Dehaen W. Fokin VV. Van der Eycken E. Org. Lett.  2004,  6:  4223 
    CrossrefGoogle Scholar
  • 14 Hansen SG. Jensen HH. Synlett  2009,  3275 
    Article in Thieme ConnectGoogle Scholar